A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.

J Child Adolesc Psychopharmacol · 2020 · PMC7409584 · PMID 32460523

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

43.2%), but the difference did not reach statistical significance.

also in 111,027 other papers

failed to reach statistical significanceno p-value reported

Patients receiving fluoxetine were numerically more improved compared to those receiving vilazodone and placebo, but these improvements failed to reach statistical significance for the primary or secondary endpoint.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.